Ae. Bendel et al., A RECOMBINANT FUSION TOXIN TARGETED TO THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR, Leukemia & lymphoma, 25(3-4), 1997, pp. 257
Human granulocyte-macrophage colony stimulating factor (GMCSF) and its
high affinity receptor function to regulate the proliferation and dif
ferentiation of myeloid lineage hmatopoietic cells, and may participat
e in the pathogenesis of many malignant myeloid diseases. We have used
genetic engineering based on the elucidated molecular structures of h
uman granulocyte-macrophage colony-stimulating factor and diphtheria t
oxin (DT) to produce a recombinant fusion toxin, DT(ct)GMCSF, that tar
gets diphtheria toxin to high affinity GMCSF receptors expressed on th
e surface of blast cells from a large fraction of patients with acute
myeloid leukemia (AML). DT,,GMCSF was specifically immunoreactive with
antidiphtheria toxin and anti-GMCSF antiseras, and exhibited the char
acteristic catalytic activity of diphtheria toxin, catalyzing the in v
itro ADP-ribosylation of purified elongation factor 2. The cytotoxic e
ffects of DT(ct)GMCSF were examined using the 3-(4,5-dimethylthiazol-2
-yl)-2,5-tetrazolium (MTT) bromide assay of cell viability and in vivo
assays of protein synthesis inhibition. DT(ct)GMCSF were specifically
cytotoxic to human leukemia cell lines bearing high affinity receptor
s for human GMCSF with IC50 Of 10(-9) to 10(-11)M. It was not toxic to
mammalian hematopoietic cell lines lacking human GMCSF (hGMCSF) recep
tors. In receptor positive cells, cytotoxicity can be specifically blo
cked by a large excess of hGMCSF, confirming that its cytotoxicity is
mediated through the hGMCSF receptor. Though DT(ct)GMCSF inhibited gra
nulocyte-macrophage colony formation by committed myeloid progenitor c
ells (CFU-GM), it did not significantly affect erythroid burst formati
on by committed erythroid progenitor cells (BFU-E), or mixed granulocy
te-erythroid-macrophage-megakaryocyte colony formation by pluripotent
multilineage progenitor cells (CFU-GEMM). DT(ct)GMCSF holds promise fo
r the treatment of myeloid lineage malignancies, and is a useful reage
nt to study hematopoiesis.